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the independent predictors of 3 year adverse events.
Independent Predictors of 3-year MACE, Death and MI in Women
Conclusion: In the HORIZONS-AMI study smoking was an independent predictor of
MACE, death and reinfarction in women after acute myocardial infarction. Diabetes
was a predictor for MACE and reinfarction.
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Background: The SPIRIT Women Study provides a characterization of the female
population undergoing stent implantation with emphasis on the evaluation of the safety
and efficacy of the XIENCE V Everolimus Eluting Coronary Stent (EES) (Abbott
Vascular, Santa Clara, USA).
Methods: The SPIRIT Women Single Arm Study is a prospective, open label study
designed to assess outcomes, when EES is used in females in a real-world situation.
Results: A total of 1,572 women with coronary artery disease undergoing percutaneous
coronary intervention were enrolled at 73 international sites between July 2007 and
March 2009. Patients suitable to be treated with up to 4 planned stents, reference vessel
diameter between 2.25 mm and 4.0 mm and lesion length of ≤ 28 mm were eligible,
including patients with acute coronary syndromes. Patients with a previously implanted
stent within the target vessel were excluded. The patient population included 34%
diabetics, 64% and 78% requiring medication for hypercholesterolemia and
hypertension respectively. The mean pre-procedure percent diameter stenosis was 83%
with 29% of lesions ≥ 20mm in length. The mean number of target lesions treated was
1.4. At 1 year, the primary endpoint of all death, myocardial infarction and target vessel
revascularization was 11.9%. One year results included stent thrombosis rate (0.59 %
definite and probable), cardiac death (0.8%), and TLR (2.4%).
Conclusion: This study represents the longest term outcome for EES reported to date
on a large ‘real world’ female population of patients outside of the United States. Two
year follow up rate for the study is 95%. Final adjudication of all clinical events is
ongoing. The 2 year clinical results of the SPIRIT Women Single Arm Study will be
presented and discussed.
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Non-atherosclerotic coronary artery disease in young women
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Background: Non-atherosclerotic CAD (NACAD) is an important cause of MI in
young women, but is often missed on coronary angiography. Our group previously
described the angiographic appearance of coronary fibromuscular dyplasia (FMD), but
the prevalence of this and other NACAD in young women have not been described.
Methods: We retrospectively reviewed all women aged ≤50 who underwent coronary
angiography at Vancouver General Hospital from April 1/2010 to April 30/2011. The
baseline characteristics and medication use were recorded. The angiograms were
reviewed meticulously and reported as normal or mild CAD (<30% stenosis),
atherosclerotic CAD (ACAD), or NACAD. NACAD is further characterized as
coronary dissection, coronary FMD (abrupt transition to diffuse obliterative disease
from a mid to distal coronary artery), ectasia, vasculitis, embolism, congenital anomaly,
or unclear etiology.
Results: Of 4318 coronary angiograms performed, 99 were done in women ≤50. The
mean age was 45±5 (range 31-50), average BMI 27, 19% had diabetes, 37%
dyslipidemia, 40% hypertension, 14% smokers, and 30% had ischemia on stress tests.
The majority (64) had acute coronary syndrome (ACS), and 41 had elevated troponin.
There were 49 with normal or mild CAD (2 Takotsubo cardiomyopathy), and 25 had
ACAD. Twenty (20.2%) had NACAD, of which 14 had coronary dissection or FMD
(13 had ACS). Four had spontaneous coronary dissection: 3 proven on optical
coherence tomography, and a 11 months post-partum retrograde dissection into left
main requiring CABG. Ten had diffuse mid-distal disease consistent with coronary
FMD (could not exclude concurrent coronary dissection), 9 had elevated troponin, and
4 had FMD in another vascular territory. Less common NACAD were suspected
vasculitis in 2 (pulmonary aspergillosis plus eosinophilia, and SLE), and coronary
ectasia in 4 women. Three women with ACS had disease that could not be distinguished
between ACAD or NACAD. Among women with elevated troponin ACS (41/99): 12
(29.3%) had normal or mild CAD (2 Takotsubo), 10 (24.4%) had ACAD, 16 (39.0%)
had NACAD [12 (29.3%) had coronary dissection or FMD, 2 vasculitis, and 2 ectasia],
and 3 had unclear etiology.
Conclusion: Non-atherosclerotic CAD is seen frequently among young women
undergoing coronary angiography, particularly those presenting with MI. Coronary
dissection or FMD is the most commonly encountered NACAD in young women, and
should be better characterized to avoid missed diagnosis.
TCT-423
Higher Rates of Repeat Revascularization in Young Women Undergoing
Percutaneous Coronary Intervention: Results from the NHLBI Dynamic
Registry
Kelly C Epps1, Sarah K Gualano2, Elizabeth M Holper2, Helen Vlachos3, Faith
Selzer3, J. Dawn Abbott5, Alice K Jacobs4, Michael Luna2, Oscar C Marroquin6,
Srihari S Naidu8, Vankeepuram S Srinivas7, Robert L Wilensky1
1Department of Internal Medicine, Division of Cardiology, Hospital of the
University of Pennsylvania, Philadelphia, PA; 2Department of Internal Medicine,
Division of Cardiology, University of Texas Southwestern, Dallas, TX; 3Graduate
School of Public Health, University of Pittsburgh, Pittsburgh, PA; 4Department of
Medicine, Section of Cardiology, Boston Universtiy Medical Center, Boston, MA;
5Rhode Island Hospital, Division of Cardiology, Providence, RI; 6Department of
Medicine, Division of Cardiology, University of Pittsburgh Medical Center,
Pittsburgh, PA; 7Cardiovascular Division, Jack D. Weiler Hospital of Montefiore
Medical Center, Bronx, NY; 8Division of Cardiology, Winthrop University Hospital,
Mineola, NY
Background: Although young women are at low risk for developing atherosclerosis,
they may be at high risk for recurrent events once CAD is evident. There are limited
data on medium-term outcomes in young women undergoing PCI.
Methods: We evaluated 3797 women undergoing PCI enrolled in the NHLBI Dynamic
Registry and compared demographic and angiographic data, in-hospital and 1 year
outcomes in women <50 years (n=394) with women ≥50 years old (n=3403).
Results: Compared to women ≥ 50, younger women had lower rates of diabetes (31.9
vs. 38.3%, p=0.01), hypertension (61.4 vs. 79.0%, p<0.001), and hyperlipidemia (62.9
vs. 70.4%, p=0.003) but were more likely to be black (25.6 vs. 15.7%, p<0.001) and
current smokers (52.6 vs. 19.1%, p<0.001). In-hospital adverse event rates for younger
compared to women ≥ 50 were lower or equivalent (death 0.3 vs. 1.5%, p=0.04, MI
1.3 vs. 2.2%, p=0.22, CABG 0.8 vs. 1.0%, p=0.65). Despite less extensive CAD in
younger compared to women ≥ 50 (mean significant lesions 2.2 vs. 2.9, p<0.001),
women <50 were more likely to require repeat revascularization at 1 year (figure).
One-year adjusted relative risks (RR) for younger women using women ≥ 50 as the
reference are: death 0.4 (95% CI 0.2-0.9, p=0.03), CABG 2.2 (95% CI 1.5-3.3,
p<0.001), repeat PCI 1.9 (95% CI 1.5-2.5, p<0.001), and TVR 2.1 (95% CI 1.5-2.8,
p<0.001).
One Year CABG/Repeat PCI Rates for the Dynamic Registry Women
Conclusion: Despite fewer risk factors and less extensive CAD, younger women have
higher repeat revascularization rates after PCI. Plausible explanations include 1) higher
prevalence of smoking, 2) aggressive surveillance or 3) aggressive atherosclerotic and
restenotic phenotypes in young women.
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Do Women Continue to have Longer Door-to-Balloon Times in the Era of
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Background: Prior studies suggest that women presenting with STEMI have longer
door-to-balloon times. We sought to determine if gender differences persists within the
context of a regional primary PCI program.
Methods: We identified pts referred for Primary PCI from the University of Ottawa
Heart Institute STEMI database. We compared baseline demographics, door-to-balloon
times, and hospital mortality in men and women. Logistic regression analysis was
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